Home/Filings/4/0001628280-25-026955
4//SEC Filing

Lachance Carrie 4

Accession 0001628280-25-026955

CIK 0001337013other

Filed

May 19, 8:00 PM ET

Accepted

May 20, 6:55 PM ET

Size

15.6 KB

Accession

0001628280-25-026955

Insider Transaction Report

Form 4
Period: 2025-05-16
Lachance Carrie
DirectorPresident and COO
Transactions
  • Tax Payment

    Common Stock

    2025-05-17$6.15/sh6,090$37,454201,849 total
  • Award

    Stock Options (right to buy)

    2025-05-16+74,22874,228 total
    Exercise: $6.00From: 2026-05-16Exp: 2035-05-16Common Stock (74,228 underlying)
  • Award

    Stock Option (right to buy)

    2025-05-16+128,000128,000 total
    Exercise: $6.00From: 2026-05-16Exp: 2035-05-16Common Stock (128,000 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2025-05-1717,7270 total
    Common Stock (17,727 underlying)
  • Exercise/Conversion

    Common Stock

    2025-05-17+17,727207,939 total
  • Award

    Restricted Stock Units

    2025-05-16+31,25031,250 total
    From: 2026-05-16Exp: 2028-05-16Common Stock (31,250 underlying)
Holdings
  • Common Stock

    190,212
Footnotes (5)
  • [F1]Represents the withholding of the Issuer's common stock for the tax liability associated with the vesting and settlement of the common stock issued on May 17, 2025
  • [F2]The option, representing the right to purchase a total of 74,228 shares of InfuSystem Holdings, Inc. common stock, vests in four equal annual installments beginning May 16, 2026.
  • [F3]Restricted stock units convert into common stock on a one-for-one basis.
  • [F4]These restricted stock units vest in three equal annual installments beginning on May 16, 2026.
  • [F5]These restricted stock units cliff vested on May 17, 2025.

Issuer

InfuSystem Holdings, Inc

CIK 0001337013

Entity typeother

Related Parties

1
  • filerCIK 0001790024

Filing Metadata

Form type
4
Filed
May 19, 8:00 PM ET
Accepted
May 20, 6:55 PM ET
Size
15.6 KB